A Fellow of the ACS since 1999, Dr. Brown is a professor of surgery at Weill Cornell Medical College in New York, NY. In addition, she is the senior vice-president and chief health equity officer, Nicholls-Biondi Chair for Health Equity, and vice-chair of health equity in the Department of Surgery at Memorial Sloan Kettering (MSK), also in New York City. Dr. Brown is a former member of original Cancer Moonshot, which President Biden initiated in 2016 when he was Vice President. The Cancer Moonshot resumed work in 2022 with the release of the President’s Cancer Panel Report, “Closing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Access,” which the ACS supported and in which Dr. Brown noted the importance of joint efforts to improve access and equity in cancer care. Throughout her career, Dr. Brown has provided high-quality cancer care to women, addressed disparities in cancer care and outcomes, and advocated for improved public policy for gynecologic and other cancers. Her health equity roles at MSK allow Dr. Brown to address the social determinants of health that affect cancer health outcomes. She has been integral to managing the Cancer Health Equity research program, which allows underserved patients to participate in MSK clinical trials.
Selected publications from PubMed
Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers.
Noiret B, Perez RO, Conroy T, Brown CJ, Schrag D, Fernandez L, Lefevre JH, Benoist S, Rouanet P, Garcia-Aguilar J, Denost Q
J Clin Oncol. 2026 Apr 10;44(11):1016-1027 doi: 10.1200/JCO-25-01861.
Point-of-Care CagA Antibody Positivity and Its Association with Precancerous Gastric Changes.
Kumar S, Goldberg DS, Zaika E, Yow MV, Brown CM, Paulrasu K, Montgomery EA, Morgan DR, El-Rifai W, Zaika A
Cancer Prev Res (Phila). 2026 Feb 6;19(2):73-77 doi: 10.1158/1940-6207.CAPR-25-0325.
Global benchmarks for minimally invasive right hemicolectomy for cancer.
Abbassi F, Ramser M, Pfister M, Staiger RD, Kim SJ, Park JW, van de Laar BCT, Gonzalez M, Perano V, Camilleri G, Merino D, Dourado J, Wignakumar A, Shigeta K, Mansur Duarte de Miranda Marques T, Leonard D, Lee KY, Saklani A, Brown KGM, Butti F, Raguz I, Schena CA, Kitaguchi D, Winter DC, Ito M, de'Angelis N, Hahnloser D, Vu J, Desouza A, Siew BE, Tan KK, Kartheuser A, Aguiar S Jr, Okabayashi K, Brown CJ, Wexner S, Biondo S, Miskovic D, Spinelli A, Vaccaro CA, Consten ECJ, Min BS, Puhan MA, Turina M
Br J Surg. 2025 Nov 29;112(12) doi: 10.1093/bjs/znaf259.
Comparative transcriptomic analysis of tumor- infiltrating canine natural killer cells and candidate biomarkers from first-in-dog NK immunotherapy trials.
Razmara AM, Lammers M, Judge SJ, Sholevar CJ, Murphy WJ, Gaskill CE, Culp WTN, Gingrich AA, Morris ZS, Rebhun RB, Brown CT, Vail DM, Kent MS, Canter RJ
Front Immunol. 2025;16:1646849 doi: 10.3389/fimmu.2025.1646849.
Knowledge-informed multimodal cfDNA analysis improves sensitivity and generalization in cancer detection.
De Falco A, Grisolia P, Giuffrida R, Iannarone C, Graziano C, Scrima M, Cossu AM, Tufano R, Yow MV, Brown CM, Bajaj P, Bocchetti M, Nuzzo PV, Morgillo F, Caraglia F, Delle Corte MC, Guida GD, Troiani T, Ciardiello F, Rizzo MR, Fiorelli A, Giorgiano NM, Arcaniolo D, Rosa GD, De Sio M, Covre A, Di Giacomo AM, Calabrò L, Fontana P, Mare M, Landgren O, Green DJ, Lesokhin A, Coffey DG, Merchant N, Datta J, Forte S, Maio M, Caraglia M, Ceccarelli M
bioRxiv. 2025 Oct 21 pii: 2025.10.20.683167. doi: 10.1101/2025.10.20.683167.
Help your network discover Dr. Carol Brown's clinical expertise.
